Artículos científicos Open Access

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
The New England Journal of Medicine; 382:1199-1207
Qun Li, M.Med., Xuhua Guan, Ph.D., Peng Wu, Ph.D., Xiaoye Wang, M.P.H., Lei Zhou, M.Med., Yeqing Tong, Ph.D., Ruiqi Ren, M.Med., Kathy S.M. Leung, Ph.D., Eric H.Y. Lau, Ph.D., Jessica Y. Wong, Ph.D., Xuesen Xing, Ph.D., Nijuan Xiang, M.Med., et al.
First Case of 2019 Novel Coronavirus in the United States
The New England Journal of Medicine; 382:929-936
Michelle L. Holshue, M.P.H., Chas DeBolt, M.P.H., Scott Lindquist, M.D., Kathy H. Lofy, M.D., John Wiesman, Dr.P.H., Hollianne Bruce, M.P.H., Christopher Spitters, M.D., Keith Ericson, P.A.-C., Sara Wilkerson, M.N., Ahmet Tural, M.D., George Diaz, M.D., Amanda Cohn, M.D., et al., for the Washington State 2019-nCoV Case Investigation Team
Clinical Characteristics of Coronavirus Disease 2019 in China
The New England Journal of Medicine
Wei-jie Guan, Ph.D., Zheng-yi Ni, M.D., Yu Hu, M.D., Wen-hua Liang, Ph.D., Chun-quan Ou, Ph.D., Jian-xing He, M.D., Lei Liu, M.D., Hong Shan, M.D., Chun-liang Lei, M.D., David S.C. Hui, M.D., Bin Du, M.D., Lan-juan Li, M.D., et al., for the China Medical Treatment Expert Group for Covid-19
A Novel Coronavirus from Patients with Pneumonia in China, 2019
The New England Journal of Medicine; 382:727-733
Na Zhu, Ph.D., Dingyu Zhang, M.D., Wenling Wang, Ph.D., Xingwang Li, M.D., Bo Yang, M.S., Jingdong Song, Ph.D., Xiang Zhao, Ph.D., Baoying Huang, Ph.D., Weifeng Shi, Ph.D., Roujian Lu, M.D., Peihua Niu, Ph.D., Faxian Zhan, Ph.D., et al., for the China Novel Coronavirus Investigating and Research Team
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
International Journal of Antimicrobial AgentsVolume 55, Issue 3
Chih-Cheng Lai, Tzu-Ping Shih, Wen-Chien Ko, Hung-Jen Tang, Po-Ren Hsueh
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
Journal of Microbiology, Immunology and Infection
Chih-Cheng Lai, Yen Hung Liu, Cheng-Yi Wang, Ya-Hui Wang, Po-Ren Hsueh
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
Journal of Pharmaceutical Analysis
Muhammad Tahir ul Qamar, Safar M. Alqahtani, Mubarak A. Alamri, Ling-Ling Chen
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
International Journal of Antimicrobial Agents
Christian A. Devaux, Jean-Marc Rolain, Philippe Colson, Didier Raoult
Molecular immune pathogenesis and diagnosis of COVID-19
Journal of Pharmaceutical Analysis
Xiaowei Li, Manman Geng, Yizhao Peng, Liesu Meng, Shemin Lu
COVID-19 infection: origin, transmission, and characteristics of human coronaviruses
Journal of Advanced Research
Muhammad Adnan Shereen, Suliman Khan, Abeer Kazmi, Nadia Bashir, Rabeea Siddique
Coronavirus Disease 2019: Coronaviruses and Blood Safety
Transfusion Medicine Reviews
Le Chang, Ying Yan, Lunan Wang
COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives
Trends in Molecular Medicine
Jiumeng Sun, Wan-Ting He, Lifang Wang, Alexander Lai, Shuo Su
Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient
Kidney Medicine
Bin Tang, Sijia Li, Yuwan Xiong, Ming Tian, Shuangxin Liu

Página 483 de 490

Síguenos en nuestras redes sociales

Suscríbete a nuestro Boletín Institucional
INSP logo
© 2022 INSP. Todos los derechos reservados.